New Fortress Energy
NFE
Lantheus
LNTH
Dorian LPG
LPG
eBay
EBAY
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US Stock MarketDetailed Quotes
OCUL Ocular Therapeutix
- 6.500
- +0.575+9.70%
Close Mar 4 16:00 ET
- 6.510
- +0.010+0.15%
Post 20:01 ET
1.03BMarket Cap-5.33P/E (TTM)
6.630High5.785Low2.95MVolume5.820Open5.925Pre Close18.81MTurnover2.37%Turnover RatioLossP/E (Static)159.02MShares11.77552wk High3.28P/B806.79MFloat Cap4.06052wk Low--Dividend TTM124.12MShs Float44.190Historical High--Div YieldTTM14.26%Amplitude1.995Historical Low6.388Avg Price1Lot Size
About Ocular Therapeutix Company
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Company Profile
SymbolOCUL
Company NameOcular Therapeutix
Listing DateJul 25, 2014
Issue Price13.00
Founded2006
CEODr. Pravin U. Dugel, M.D.
MarketNASDAQ
Employees267
Fiscal Year Ends12-31
Address15 Crosby Drive
CityBedford
ProvinceMassachusetts
CountryUnited States of America
Zip Code01730
Phone1-781-357-4000
Websitehttp://www.ocutx.com
Company Executives
- Name
- Position
- Salary
- Dr. Pravin U. Dugel, M.D.
- Executive Chairman of the Board, President and Chief Executive Officer
- --
- Dr. Nadia Waheed, M.D.
- Chief Medical Officer
- --
- Dr. Jeffrey S. Heier, M.D.
- Chief Scientific Officer
- 329.90K
- Donald Notman
- Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer
- 1.34M
- Dr. Sanjay Nayak, M.B.B.S.,PhD
- Chief Strategy Officer
- --
- Peter Kaiser, M.D.
- Director, Medical
- --
- Charles Warden
- Lead Independent Director
- 303.61K
- Dr. Richard L. Lindstrom,M.D.
- Independent Director
- 261.11K
- Merilee Raines
- Independent Director
- 263.61K
- Dr. Seung Suh Hong, PhD
- Independent Director
- 248.61K
- Dr. Adrienne L. Graves,PhD
- Independent Director
- 397.89K
- Leslie J. Williams
- Independent Director
- 261.11K
- Philip C. Strassburger
- General Counsel
- --